Migraine is a common and debilitating neurological disorder suffered worldwide. Women experience this condition 3 times more frequently than men, with estrogen strongly implicated to play a role. Bisphenol A (BPA), a highly prevalent xenoestrogen, is known to have estrogenic activity and may have an effect in migraine onset, intensity, and duration through estrogen receptor signaling. It was hypothesized that BPA exposure exacerbates migraine symptoms through estrogen signaling and downstream activation of nociception related pathways. Utilizing a multibehavior model of migraine in ovariectomized female rats, changes in locomotion, light and sound sensitivity, grooming, and acoustic startle were examined. Furthermore, changes in the expression of genes related to estrogen (ERα, GPR30), and nociception (extracellular signal regulated kinase, ERK, sodium gated channel, Na v 1.8, and fatty acid amide hydrolase, FAAH) were studied following behavioral experiments. The following results were obtained: BPA treatment significantly exacerbated migraine-like behaviors in rats. Rats exposed to BPA demonstrated decreased locomotion, exacerbated light and sound aversion, altered grooming habits, and enhanced startle reflexes. Furthermore, BPA exposure increased mRNA expression of estrogen receptors, total ERK mRNA and ERK activation, as well as Na v 1.8, and FAAH mRNA, indicative of altered estrogen signaling and altered nociception. These results show that BPA, an environmentally pervasive xenoestrogen, exacerbates migraine-like behavior in a rat model and alters expression of estrogen and nociception-related genes.
Migraine is a debilitating and common neurological condition that results in over 68.6 million visits to physician's offices or emergency rooms in the United States each year (Shapiro and Goadsby, 2007) . This condition creates a substantial burden to society due to the high prevalence, loss of productivity, and the high cost of treatment. Women experience migraine 3 times more frequently than men (Buse et al., 2013) , and while the mechanism behind this sex difference is not well understood, estrogen has been strongly implicated to play a role (Gupta et al., 2011; Somerville, 1975) .
A multibehavioral model of migraine in rat was developed, based on clinical diagnostic criteria from the International Classification of Headache Disorders (ICHD-II and ICHD-III) (Society, 2004; Society, 2013) . Currently, migraine has no specific biomarker test and analysis of symptoms is the only way to diagnose this disorder. Commonly described symptoms include photo-and phonophobia, avoidance of routine activity, and a unilateral pulsating pain in the head and face. The model utilized in this study expanded upon previous work (Stucky et al., 2011) to further study criteria including photoand phonophobia, facial allodynia, and enhanced acoustic startle. Rats received a dural cannula implant and an inflammatory soup (IS), a well-established model for migraine study in rats (Burstein et al., 1998) , was applied to the dura mater to induce migraine-like behaviors. Total locomotor activity (ie, routine activity) (Stucky et al., 2011) , photo-and phonophobia (light and noise aversion), evoked grooming, and acoustic startle reflex were then examined.
It is important to note that estrogen receptors ERalpha and GPR30 are present in trigeminal nociceptors, and through estrogen binding, downstream activation of the pain-related extracellular signal regulated kinase (ERK) occurs (Liverman et al., 2009a) . It has also been demonstrated that environmental estrogens can bind to and activate estrogen receptors, leading to altered cell activity (Lapensee et al., 2009) . Bisphenol A (BPA) is used in plastics manufacturing and is one of the most ubiquitous xenoestrogens, leading to frequent human exposure. It is estimated that over 90% of the U.S. population has BPA in their bodies (Calafat et al., 2008) , and while the effect of BPA exposure in cancer has been extensively studied (De Coster and van Larebeke, 2012) , little is known regarding its consequences in terms of migraine and other pain syndromes. Furthermore, current standard toxicology screenings do not explore the effect BPA may have on migraine onset, intensity and duration. While the EPA has deemed the safe maximum dose of BPA to be 50 μg/kg/day (Leranth et al., 2008) , it is estimated that many humans are exposed to levels approximately 10 times this amount (Vandenberg et al., 2007 (Vandenberg et al., , 2009 (Vandenberg et al., , 2012 (Vandenberg et al., , 2013 . As BPA is able to bind to estrogen receptors known to be involved in exacerbating trigeminal pain (Liverman et al., 2009a) , it is likely BPA exposure could contribute to the development of migraine or could increase the severity of migraine symptoms.
While previous work has investigated the effect of other environmental estrogens and pain (Ceccarelli et al., 2009) , no studies have established how exposure to BPA alters migraine symptoms. Furthermore, many pain disorders demonstrate female predominance; including, irritable bowel syndrome, fibromyalgia, and temporomandibular disorders (Chang and Lu, 2013) . Therefore, chronic, daily exposure to BPA may have detrimental effects on the symptoms of a variety of diseases. The goal of this study was to determine whether BPA exposure exacerbates migraine symptoms and alters migraine pathogenesis through estrogen signaling and downstream activation of nociceptive pathways.
MATERIAls ANd METHods
Materials. Bisphenol A (BPA), prostaglandin E 2 , bradykinin acetate, histamine dihydrochloride, serotonin hydrochloride, sterile water, and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.
Animals. Animal care and use procedures were approved by the University of Kansas Medical Center Institutional Animal can and use committee and conducted according to Institute of Laboratory Animal Research guidelines. Tenweek-old, female, sexually mature, ovariectomized Sprague-Dawley rats were purchased from Charles River Laboratories (Wilmington, MA). The animals were housed in the Laboratory Animal Resources Facility on 12-h light-dark cycle and provided water and food ad libitum. They were provided a diet of soy and alfalfa free pellets (Teklad 2020x, Harlan Laboratories, Indianapolis, IN) to minimize the presence of dietary phytoestrogens. Rats were divided into groups based on application of inflammatory soup [IS, 1.0 mM bradykinin acetate, 1.0 mM histamine dihydrochloride, 1.0 mM serotonin hydrochloride, and 0.1 mM prostaglandin E 2 in sterile PBS, pH 5.5 (Burstein et al., 1998) ] or phosphate buffered saline (PBS, adjusted to a pH of 7.4) and exposure to BPA or vehicle corn oil. Animal numbers per group: IS control: 6 rats, IS+BPA: 7 rats, PBS control: 7 rats, PBS+BPA: 7, ovariectomized controls: 4 rats. All behavioral experiments were conducted between 9:00 and 14:00 h in a dedicated, temperature-controlled room.
Cannula implantation. A Plastics One (Roanoke, VA) cannula made of biocompatible material was used for dural delivery of IS or PBS. The cannula was implanted through the skull under isoflurane anesthesia as previously described in detail (Stucky et al., 2011) . Briefly, the cannula was placed on the right side of the skull over the occipital lobe 5 mm lateral to midline and halfway between bregma and lambda. One stainless steel screw was placed in rostral and caudal positions 3 mm from the center of the cannula as anchors for the dental cement (Ortho-Jet, Lang Dental Mfg. Co., Inc., Wheeling, IL) used to stabilize the cannula.
Treatment. Bisphenol A was dissolved in 70% ethanol while being slightly heated and stirred. An aliquot was then diluted 100-fold (ethanol final concentration 0.7%) in corn oil to a final concentration of 500 μg/ml. Rats were dosed intraperitoneally (IP) at 500 μg/kg/day (Pottenger et al., 2000) . This dose was based on several extensive literature studies investigating predicted human exposure based on levels of BPA and metabolites found in urine samples (Vandenberg et al., 2007 (Vandenberg et al., , 2009 (Vandenberg et al., , 2012 (Vandenberg et al., , 2013 . Rats were divided into groups which received either BPA or a vehicle (corn oil) injection. Rats received IS or PBS through the cannula implant. During application, the obturator cap was removed; an internal delivery cannula was placed, and was connected to PE50 tubing. An infusion pump (Cole Parmer, Vernon Hills, IL) was used to deliver 10 μl of IS or PBS at a rate of 2 μl/min for 5 min. Subjects were weighed prior to behavioral testing throughout the course of the study, and there were no statistical differences in weight between BPA and vehicle exposed rats.
Timeline. Prior to the surgery, rats acclimated for 1 week, and then were subjected to 2 days of presurgical baseline behavior testing. On the following day, rats were implanted with the cannula and given a week to recover. Rats then performed 2 days of postsurgical baseline testing. No IS, PBS, corn oil, or BPA were present during pre-and postsurgical days.
Behavioral testing with IS application and BPA exposure was performed every third day for 7 total applications following the postsurgical baseline. Fifteen minutes prior to the cannula application of IS, rats were injected intraperitoneally (IP) with either BPA or vehicle (corn oil). Behavioral testing was completed between 0 and 30 minutes following the application of IS as this is when cutaneous allodynia is greatest (Oshinsky and Gomonchareonsiri, 2007) . Rats were decapitated after anesthesia with pentobarbital sodium (Beuthanasia, D, Schering-Plough, Summit, NJ) at a dose of 60 mg/kg (IP) following recommendations of the Panel on Euthanasia, American Veterinary Medical Association, approximately 1 hr following the final dural application. The brain and cervical spinal cord were removed and placed in RNALater (Ambion, Foster City, CA) and kept for 2-3 days at 4°C. Ipsilateral trigeminal nucleus and dura mater were dissected as previously described (Stucky et al., 2011) .
MUlTIBEHAvIoR ModEl oF MIGRAINE
Locomotor activity. A force plate actimeter (BASi, San Diego, CA), which was placed in a sound attenuating chamber, was used to assess locomotor activity. Total distance traveled (mm) and bouts of low mobility (BLM) were assessed as previously described (Stucky et al., 2011) . Activity was measured for 3 subsets of time: 0-5 min (application of IS, "delivery phase"), 6-10 min ("onset phase"), and 11-15 min ("persistence phase"). This behavioral analysis models the ICHD-II and ICHD-III's classification of "a decrease in routine physical activity" during a migraine attack (Society, 2004; Society, 2013) .
Photo-and phonophobia. The force plate actimeter was modified to assess light and noise aversion. An opaque wall, containing sound-attenuating material, was placed in the center of the box with an opening large enough for the rat to move freely between the two sides. Rats were given 5 min to acclimate to the arena while both sides of the enclosure were dark and quiet. Following the acclimation period, a remotely controlled light was turned on to an illumination of 250 lux on one side of the chamber. Following a 5 min time for the rat to explore the light and dark sides, the rats were allowed a 2 min rest period in the absence of light. Remotely controlled speakers were then activated to emit a 75 dB white noise on one side of the chamber (quiet side measured at a sound intensity of approximately 45 dB) and the rats were monitored for a further 5 min and allowed to freely choose the noise or quiet sides. This behavioral assessment models human photo-and phonophobia experienced during a migraine. Both are part of the ICHD-II and III diagnostic criteria (Society, 2004; Society, 2013 ). An artist's rendition of the divided force plate set up can be found in Supplementary Figure S1 .
Evoked grooming. Rats were placed in a clean cage and recorded for approximately 1 min to determine baseline grooming habits. Three metered sprays of water were applied using a spray bottle and the rats were filmed for an additional 5-6 min to assess grooming. Only grooming to the face and head was quantified, with a cleaning swipe defined as the use of one or both forepaws to clean the area at or above the eyes. A cleaning bout was the time spent cleaning the head or face and the bout was considered terminated when the rat initiated a different activity or moved to a new location. This behavioral assay models facial allodynia that migraine sufferers often experience during an episode (Burstein et al., 1998; Society, 2013) .
Acoustic startle reflex. Startle reflex was assessed using a Kinder Scientific Startle Reflex Chamber (Kinder Scientific, Poway, CA). Rats were allowed 5 min to acclimate to the chamber. Subsequently, a series of 14 randomly mixed auditory pulses (85 or 90 dB) were emitted at 1 pulse/min. The maximum force (N) of the startle response in the 80 msec immediately following the noise was recorded, and the average maximum response per 7 trials was determined. This behavioral assay models enhanced phonophobic response migraine sufferers may experience during a headache (Afra et al., 2000; Duncko et al., 2008) .
Gene expression analysis. Following dissection of the brain (trigeminal nucleus, TGN; dura mater), total RNAs from each sample was extracted, purified, and quantified using a Nanodrop as previously described using GAPDH as an internal control (Stucky et al., 2011) . Gene-specific primers were chosen (see Supplementary Table S1 ) and qPCR was performed in a 96-well MicroAmp Optical reaction plate.
pERK analysis. SDS-PAGE gels were cast with a 4% acrylamide stacking layer and 10% resolving layer to quantify levels of phosphorylated ERK. Samples were isolated as previously described (Liverman et al., 2009a) and 10 µg of protein were loaded for each sample and transferred to nitrocellulose via wet transfer. Membranes were blocked using the Odyssey blocking buffer for 2 hr at room temperature and then incubated overnight at 4°C with anti-pERK-specific antibody (1:10 000). Following 3 washes with tris-buffered saline with 0.1% Tween 20, membranes were incubated for 1.5 hr at room temperature with fluorescent-conjugated secondary antibody goat-antimouse Alexa Fluor 680 (1:10 000) which was detected using the Odyssey Infrared Fluorescence Imaging System. Image J was used to analyze band density and all data were normalized to β-actin as an internal control in order to determine the total amount of activated ERK.
Statistical analyses. Behavioral data were analyzed using a two-way repeated-measures ANOVA with a Bonferroni's post hoc comparison and confidence intervals using SPSS Statistics 20 (IBM, Chicago, IL) and treatment (BPA vs vehicle) was always used as the between subjects factor. Gene expression and protein data were analyzed using a one-way ANOVA and Tukey's posttest. For all behavioral data, significant differences between pre/postsurgical baselines and data at a specific time point are represented by a pound symbol (#). Significant differences between BPA and vehicle treatments are indicated by an asterisk symbol (*). Unless otherwise stated, differences were considered significant if p ≤ .05.
REsUlTs

Total Locomotor Activity Was Decreased Following BPA Exposure
Rats were given a dural application of IS following exposure to 500 μg/kg/day BPA or vehicle and the total locomotor activity was determined. BPA treatment significantly decreased locomotor activity. Total distance traveled was decreased in both BPA and vehicle treatment groups following IS treatment 1 (Fig. 1A) . These results confirm previously published data demonstrating a behavioral marker of migraine (Stucky et al., 2011) . Furthermore, BPA-treated rats exhibited significantly decreased distance traveled as compared to vehicle-treated animals, indicating exacerbation of migraine-like behaviors following BPA treatment. Bouts of low mobility (BLM), which assess inactivity in response to treatment, increased significantly over the course of the 7 treatment events for both the onset and persistence phases (Fig. 1B) , indicating increased time spent inactive due to the noxious dural stimulus (IS) treatment. Importantly, rats exposed to BPA (closed circles) demonstrated significantly decreased distance traveled and increased BLM compared to vehicle-treated rats, demonstrating that BPA exposure significantly augmented these migraine-like behaviors.
BPA Exposure Exacerbated Light and Noise Aversion
Immediately following the total locomotor study, rats were placed in a modified force place actimeter as described in the Methods to measure photo-and phonophobia. The percentage of time spent in the 250 lux-illuminated chamber compared to the dark chamber is reported in Figure 2A . BPA treatment decreased time spent in the light after a second dural stimulation versus pre/postsurgical baselines, while vehicle-treated rats spent less time in the light following the fourth dural stimulation compared to pre/postsurgical baselines. BPA-and vehicle-treated rats displayed no significant differences in light preference when compared to each other. BPA-treated animals demonstrated significantly increased BLM while the light stimulus was illuminated (Fig. 2B) , and BLM were significantly increased in vehicle rats following dural stimulations 2-5, when compared with pre/postsurgical baselines. BPA treatment increased numbers of BLM during exposure to the light.
Compared to pre/postsurgical days, BPA-and vehicletreated rats exhibited significantly decreased time spent in the noise stimulus following IS application (Fig. 2C) . In addition, BPA-treated rats spent significantly less time in the noise stimulus than vehicle-treated rats across dural stimulations. Analysis of the data in Figure 2D showed that both BPA-and vehicle-treated rats also exhibited increased BLM when the noise stimulus was activated following application of IS (dural stimulation 2-7 for both treatments) when compared to pre/ postsurgical days. BPA-treated groups also exhibited a significantly high number of BLM when compared to vehicle-treated rats while the noise stimulus was present. These data indicate that BPA exposure also augmented migraine-associated light and sound aversion.
BPA Exposure Produced Facial Allodynia
Following the phono-and photophobia experiments, rats were immediately placed in a clean cage and taped for approximately Data are presented as mean ± SEM and in all graphs: Pre, presurgical baseline behavior; Post, postsurgical baseline. For total distance traveled: **p ≤ .005, and for BLM: ***p ≤ .05. All statistical analysis was performed for BPA treatment compared with vehicle treatment and (n = 7 for BPA and n = 6 for vehicle).
1 min to assess baseline grooming habits. Animals were then sprayed in the face 3 times with a metered bottle of water and further filmed for 5-6 min. Rats exposed to BPA exhibited an increased latency to groom compared to pre/postsurgical days and compared to vehicle-treated rats following the first dural stimulation. Vehicle-treated rats did not show this effect until dural stimulation 5 (Fig. 3) .
Exposure to BPA Enhanced Startle Reflex
Finally, following completion of the grooming experiment, rats were placed in Kinder Scientific Startle Reflex boxes to determine whether BPA treatment altered this response. To model enhanced acoustic startle observed in human migraine sufferers (Afra et al., 2000) , the startle response was measured in the animal groups using two different intensities of sound. At a sound stimulus intensity of 85 dB, both BPA-treated and vehicle-treated rats demonstrated similar levels of startle reflex, with no significant differences (data not shown). At a sound stimulus intensity of 90 dB, BPA-treated rats exhibited significantly augmented startle response when compared to vehicle-treated rats (Fig. 4) . Rats given BPA also displayed significantly augmented response as compared to pre/postsurgical baseline days.
BPA Altered Expression of Estrogen-and Nociception-Related Genes
Following animal sacrifice, trigeminal nucleus (TGN) from the brainstem and dura mater (area of direct stimulation by the IS) were collected and assayed using qPCR. There were significant gene expression differences between the BPA-and vehicle-treated rats, as shown in Table 1A (TGN) and Table 1B (dura mater). In all TGN samples (Table 1A) , tissues from BPA-exposed rats contained higher levels of estrogen receptor alpha (ERα) and the G protein coupled membrane receptor GPR30 mRNAs than vehicle-treated rats. Furthermore, mRNA levels were also significantly elevated for extracellular signal regulated kinase (ERK1 and 2), and the sodium channel Na v 1.8 in the TGN of BPA-treated rats. Interestingly, both BPA-and vehicle-treated rats exhibited significant elevation of fatty acid amide hydrolase (FAAH), suggesting modification of endogenous cannabinoid signaling in both treatment groups. In the dura mater (Table 1B) , a small increase of estrogen receptor mRNA levels was found as compared to ovariectomized controls. ERK1/2 mRNA levels were significantly increased in both treatment groups, with BPA-treated rats demonstrating a 3.5-fold (ERK1) and 10.8-fold (ERK2) increase in mRNA levels compared to ovariectomized control rats. Again, both treatments (BPA or vehicle) exhibited elevated FAAH mRNA levels in the dura mater.
ERK Activation Was Increased by BPA Treatment
Western blot analysis for phosphorylation of ERK was used to examine ERK activation. Figure 5A shows a representative gel for pERK analysis in protein samples from the TGN. Densitometric analysis using ImageJ revealed a significant   FIG. 4 . Acoustic startle reflex. Acoustic startle reflex after 90 dB pulse using a Kinder Scientific Startle Reflex box to measure the 80 msec following pulse (2-way ANOVA for treatment: F(1, 430) = 16.75, p < .0001, day: F(10, 430) = 3.59, p < .0001, treatment × day interaction: F(10, 430) = 5.37, p < .0001). Data are presented as mean ± SEM and pre, presurgical baseline behavior; post, postsurgical baseline. Pound symbol (#) represents BPA and no BPA compared with pre/postsurgical baseline and # p ≤ .05. Asterisk symbols (*) represents BPA compared to vehicle treatment and **p ≤ .0005. All statistical analysis was performed for BPA treatment compared with vehicle treatment and (n = 7 for BPA and n = 6 for vehicle). 
FIG. 5.
pERK levels in TGN and dura. A, Representative gel of TGN staining for pERK; following graphs in (A) show average levels of pERK1 and pERK2 (n = 3 gels). B, Representative gel of dura mata staining for pERK; following graphs in (B) show average levels of pERK1 and pERK2 (n = 3 gels). Lane 1: ovariectomized control, Lanes 2-4: IS alone, Lanes 5-7: IS + BPA. Data are presented as the mean ± SEMs (n = 3 gels) when normalized to β-actin control lane. Image J analysis values were averaged (graphical data) **p < .005 when both treatment groups were compared to ovex control. increase in pERK levels in the TGN for animals exposed to BPA. Rats exposed to BPA demonstrated a 1.5-fold increase in pERK1 as compared to ovariectomized controls and a 1.1-fold increase for pERK2.
In the dura mater (Fig. 5B) , pERK levels were found to be significantly increased in BPA-exposed rats. Rats exposed to BPA exhibited a 1.8-fold increase in pERK1 levels and a 1.7-fold increase in pERK2 levels as compared to controls. Overall, these results demonstrate the ability of BPA to increase activation of the nociception-related ERK pathways through phosphorylation of this intracellular signaling factor.
BPA Exposure Led to Migraine-Like Behaviors in PBS-Treated Rats
Control rats were given a dural application of phosphate buffered saline (PBS) following exposure to 500 μg/kg/day Figure 6A shows that BPA treatment led to a significant decrease in total locomotor activity during the persistence phase after PBS dural stimulations 3-5 when compared to vehicle exposure. Furthermore, total BLM (summation of delivery, onset, and persistence phases) demonstrated a significant increase for BPA-exposed rats after PBS-dural stimulation 2, 5, and 6 (Fig. 6B) . Rats displayed no significant differences in light and noise aversion (data not shown). Figure 6C shows that BPA-treated rats exhibited a significant increase in latency to groom on PBS-stimulation days 2-7. Finally, it can be seen in Figure 6D that rats exposed to BPA also demonstrated significantly higher startle reflex after PBS dural stimulation 6 and 7 as compared to vehicle-treated rats.
dIscUssIoN
The effect of BPA exposure on migraine pathogenesis was examined in a novel multibehavioral model of migraine in rat. These experiments demonstrate two important results. First, BPA exposure led to significant augmentation of migraine-like behaviors and changes at the genetic level in estrogen-and nociception-related genes compared to vehicle treated controls. These effects of BPA may mimic those of estrogen in the trigeminal pathways; as sensitization of the trigeminal nucleus is known to be regulated by estrogen (Cairns and Gazerani, 2009; Liverman et al., 2009b) . Second, the assessment of BPA effects in behavioral assays of photophobia and phonophobia, facial allodynia and acoustic startle that were designed to model human symptoms as described in the ICHD-II and ICHD-III provide an improved model of migraine in rat.
The behavioral measures used in this study measured a variety of parameters designed to model many of the symptoms humans experience during a migraine attack. Total locomotor activity was significantly decreased upon application of IS (Fig. 1) , reflecting a decrease in normal daily activities in human migraine sufferers (Stang and Osterhaus, 1993) . Furthermore, rats demonstrated increased phono-and photophobia (Fig. 2) , again mirroring migraineur's symptoms described in the ICHD-II (Society, 2004) . For both of these behavioral activities, BLM increased significantly, corresponding to a migraine patient's avoidance of routine activity during an attack. In both of these behavioral assays, rats exposed to BPA demonstrated significantly augmented migraine-like behaviors. These results imply that BPA has the ability to amplify symptoms that are used to diagnose the disorder in human patients, suggesting that exposure to BPA would increase both the incidence and prevalence of this disorder.
The facial grooming assay revealed that dural stimulation evoked significant facial allodynia. BPA exposure augmented this facial allodynia compared to vehicle treatment (Fig. 3) . Many migraine sufferers complain of facial allodynia, in which normally non-painful stimuli become painful during a headache episode (Bernstein and Burstein, 2012) . The data presented here show that BPA-treated animals exhibited an immediate and significant increase in their latency to groom following dural stimulation. Some reports have suggested that estrogen may contribute to widespread allodynia. For example, estrogen exposure can lead to acute and significantly increased mechanical allodynia (Zhang et al., 2012) . Furthermore, previous work involving pre-natal exposure to BPA also demonstrated the xenoestrogen had the ability to increase nociceptive-like symptoms following forepaw injection with formalin (Aloisi et al., 2002) .The current results would suggest that BPA could have a similar effect on allodynia in migraine.
Vehicle-treated rats also showed increased facial sensitivity, as demonstrated by an increased latency to groom after repeated applications of IS (Fig. 3) . These results suggest increased migraine-related facial allodynia during the course of the study, which confirms findings previously established using a similar model of migraine (Oshinsky and Gomonchareonsiri, 2007) .
Acoustic startle testing was used as an additional model of phonophobia. BPA exposure led to a significantly augmented startle response (Fig. 5) , indicating again that BPA increases migraine-like behaviors. It is important to note that there are differing reports concerning the effect of estrogen in acoustic startle response. Some studies demonstrate that estrogen-replacement following ovariectomy leads to a decrease in startle reflex (Turvin et al., 2007) , while others report that hearing sensitivity may increase in the menstrual cycle during periods of high estrogen (Al-Mana et al., 2010) . It is also important to note that there have been no previous studies involving the effect of BPA in migraine pathogenesis; therefore, comparison with previous work is not possible.
Gene expression and protein studies revealed that BPA treatment led to increased levels of mRNAs encoding estrogen-and nociception-related genes (Table 1A and1B ). The trigeminal nucleus is central to conducting pain and other somatosensory signals (Panneton et al., 2011) and is the major site of central sensitization in migraine (Burstein et al., 2011) . The dura mater is known to receive sensory innervation from the trigeminal ganglion (Levy et al., 2002) , and is also the area of direct stimulation by the IS, making it of particular interest. ERα and GPR30 gene expression was increased in the presence of BPA in each tissue. These findings confirm results of previous studies, which report that estrogen receptor mRNA levels continue to be either unchanged or slightly elevated following ovariectomy (Bohacek and Daniel, 2009) . Furthermore, studies involving BPA treatment showed an increase in estrogen receptor immunostaining in the hypothalamus region of the rat brain (Aloisi et al., 2001) are consistent with the present data.
ERK1 and ERK2 mRNA levels were significantly increased in TGN and dura mater in BPA-treated rats. Studies have established that activation of ERα or GPR30 by estrogen in the trigeminal ganglion leads to downstream activation of ERK (Liverman et al., 2009b) and the results presented here suggest that the presence of BPA leads to a similar outcome in the trigeminal nucleus. Further western blot analysis confirmed a similar elevation in activated, phosphorylated ERK1 and 2. Again, these results were significant in BPA-treated samples. This suggests downstream activation of ERK pathways through estrogen receptor binding (ERα or GPR30) by BPA led to an increased inflammatory response in both the TGN and dura. Table 1A shows significant elevation in expression of sodium gated voltage channel Na v 1.8 in both treatment groups as compared to ovariectomized controls. Studies have established that sodium channel phosphorylation by mitogen-activated proteins (MAPKs), such as ERK and p38, increases density of these receptors in trigeminal neurons (Hudmon et al., 2008) . Drugs that target sodium channels (Matulenko et al., 2009) , and more specifically Na v 1.8 (Schuelert et al., 2012) , have been shown to be an effective treatment for pain. The present study demonstrates that BPA exposure increases both Na v 1.8 gene expression and levels of activated ERK, suggesting that BPA may augment migraine symptoms and contribute to migraine pathogenesis in humans by this mechanism.
In TGN and dura mater samples, BPA-treated and vehicletreated animals exhibited elevated mRNA levels of FAAH, the chief catabolic regulator of the endogenous cannabinoid, anandamide (Ueda et al., 2000) . This confirms previous migraine studies in rats showing elevated FAAH activity (Greco et al., 2010) . Furthermore, analysis of anandamide levels in platelets of migraineurs were significantly decreased in female sufferers compared to males (Cupini et al., 2006) . These results suggest the presence of estrogen may increase anandamide catabolism in migraineurs, and that BPA exposure may cause similar results.
In control studies rats received a dural application of phosphate buffered saline (PBS). Interestingly, PBS-treated rats exposed to BPA showed behavioral changes consistent with increased nociception. Decreased locomotor activity was observed during the "persistence phase" (Fig. 6A) as well as increased total BLM (Fig. 6B) . BPA-treated rats exhibited an increased latency to groom (Fig. 6C ) and an enhanced startle reflex following a 90 dB pulse (Fig. 6D ). There were no significant differences in light and noise aversion between BPA-and vehicle-treated rats. These results suggest that BPA may have the ability to alter nociception in a person who does not suffer from migraine.
A multivariate analysis was run to compare IS dural stimulation and PBS dural stimulation following exposure to BPA or vehicle. Comparisons were made between IS control, IS+BPA, PBS control, and PBS+BPA for the following behavioral assays: Total locomotor activity during the persistence phase, evoked grooming, and acoustic startle reflex. These behavioral assays were chosen for analysis because both IS and PBS dural stimulation led to altered behavior following exposure to BPA when compared to vehicle-exposed rats. As there were no significant differences in light and noise aversion between PBS and PBS+BPA rats, a comparison was not made. It is important to note that when examining the results of IS+BPA and PBS+BPA, significant differences between these two groups were found on days 1, 2, 4, 6, and 7 of dural stimulation for the distance traveled during the persistence phase (2-way ANOVA for treatment: F(3, 187) = 9.86, p < .0001, day: F(10, 187) = 26.75, p < .0001, treatment × day interaction: F(30, 187) = 1.79, p < .010),. Comparison of exposure to BPA and dural stimulation by IS or PBS also revealed significant differences between the groups on days 2-7 of dural stimulation for latency to groom (2-way ANOVA for Treatment: F(3, 93) = 55.89, p < .0001, day: F(10, 93) = 10.85, p < .0001, treatment × day interaction: F(30, 93) = 4.58, p < .0001). Furthermore, when comparing the differences in startle reflex between these 2 groups, it was determined that rats exposed to BPA and given IS dural stimulation had a significantly enhanced startle reflex on days 1, 2, 4, 5, and 7 as compared to PBS stimulated rats also exposed to BPA (2-way ANOVA for Treatment: F(3, 866) = 12.62, p < .0001, day: F(10, 866) = 2.60, p < .004, treatment × day interaction: F(30, 866) = 4.08, p < .0001). Overall, these results indicate that while BPA exposure led to migraine-like behaviors following PBS dural stimulation, compared to IS dural stimulation, the behavioral differences were significant, with IS+BPA rats displaying exacerbated migraine-like behaviors. It is important to note though, that our control studies suggest that BPA may have the ability to enhance pain in a person who does not suffer from migraines, and these results warrant further investigation.
The current data support the hypothesis that BPA exposure leads to an increase in migraine severity and duration. We hypothesize the following pathways of activation lead to exacerbated migraine behaviors due to BPA exposure. Through both ERα and GPR30 receptor signaling, BPA leads to several changes in trigeminal neurons expressing estrogen receptors that increase sensitivity and sensitization. These include activation of MAPKs including ERK1 and ERK2 and increases in the activity of Na v 1.8 and FAAH. These, and most likely additional mechanisms, increase central sensitization in the trigeminal nucleus leading to increased migrainelike behaviors.
In conclusion, this study and its results expand upon the previously reported migraine behavioral model (Stucky et al., 2011 ) and the results demonstrate that BPA exposure can exacerbate migraine-like behaviors and alter mRNA levels of a number of nociception-related genes. A previously performed, small-scale, clinical study using a "fresh foods" dietary intervention demonstrated a significant decrease in urinary BPA (66% reduction) and metabolites (53%-56% reduction) in patients after just 3 days (Rudel et al., 2011) . These findings combined with our results suggest that a clinical trial to decrease BPA exposure and levels in migraine sufferers would lead to decreased levels of the xenoestrogen and may reduce headache frequency and/or severity, revealing strategies that may increase the quality of life of migraineurs.
